Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

The U.S. health regulator has declined to approve Zealand Pharma's drug to prevent and treat low blood sugar in children with ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

The maker of pharmaceutical inputs and bulk drugs said there was no Form 483 observation after the USFDA inspection of its ...

India's pharmaceutical and meditech exports have become the fourth-largest export sector, with 16 blockbuster drugs in the pipeline. Despite global slowdown concerns, the sector is experiencing double ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

Pressure is mounting in Congress and the regulatory agencies for changes to the drug patent system. Time will tell how fast ...

The U.S. government will be releasing a preliminary list of generic drugs that would be made available to recipients of the Medicare program for no more than $2, Axios reported on Wednesday citing U.S ...

The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...